NEWS

WIRES

OTHER

Kantar Health Names Werner Guminski CEO, Commercial Strategy

Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has appointed Werner Guminski to the position of CEO, Kantar Health Commercial Strategy. He was most recently CEO, Global Practices, at Kantar Health.

In his new role, Mr. Guminski will be responsible for developing Kantar Health's commercial strategy, which will focus on client strategy, portfolio strategy and innovation. He will continue his focus on Global Practices.

"Werner's business management experience and more than 20 years with our company make him well-qualified to take on this new role of ensuring our research and consulting services address both current and future marketplace needs," says Lynnette Cooke, CEO of Kantar Health. "He has long been intimately involved with clients and in developing Kantar Health's portfolio."

Mr. Guminski has experience in prescription brand and stakeholder management and global pricing and reimbursement strategies. He had been Managing Director of TNS Healthcare Germany, a Kantar Health legacy company, since 1989 and has been responsible for global portfolio development since 2007. Mr. Guminski joined the Board of Kantar Health as CEO for Global Practices and Region Europe in 2009.

About Kantar Health (www.kantarhealth.com)
As experts in pharmaceutical and biotechnology consulting and market research, Kantar Health offers unique insights and products that deliver proven results for marketing insights, brand marketing, business development and health economics and outcomes professionals, including:

• The greatest breadth and depth of epidemiology information in the world, spanning patient-reported outcomes and patient care by country, therapy area, specialist -- or whatever combination of data you require
• Unmatched experience in the complex oncology market that encompasses business development, clinical management, emerging technologies, marketing and sales, payers and providers, reimbursement and strategic and product planning
• A unique global source of KOLs for multiple therapy areas

Kantar Health's team combines doctorate-level scientific expertise with strong business know-how, ensuring that solutions are both evidence-based and commercially focused. We offer a wide range of expertise in emerging as well as established markets, spanning the product life cycle from product portfolio management to licensing, market access to brand and reputation management, detailing to clinical research, patient outcomes and sales force effectiveness to health and safety. And as part of WPP, the largest marketing agency in the world, Kantar Health can leverage the power of the global group with shared offline and online research methodologies but remain culturally specific and nimble. Kantar Health focuses on getting you the best return.